Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) and prothrombin G20210A heterozygosity: response to t-PA therapy
- PMID: 20107738
- DOI: 10.2340/00015555-0760
Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) and prothrombin G20210A heterozygosity: response to t-PA therapy
Similar articles
-
Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.Arch Dermatol. 2006 Nov;142(11):1466-9. doi: 10.1001/archderm.142.11.1466. Arch Dermatol. 2006. PMID: 17116837
-
Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity.J Thromb Thrombolysis. 2008 Aug;26(1):31-4. doi: 10.1007/s11239-008-0214-1. Epub 2008 Mar 23. J Thromb Thrombolysis. 2008. PMID: 18360788
-
Successful long-term use of intravenous immunoglobulin to treat livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity.Arch Dermatol. 2011 Oct;147(10):1224-5. doi: 10.1001/archdermatol.2011.274. Arch Dermatol. 2011. PMID: 22006147 No abstract available.
-
Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.Pathophysiol Haemost Thromb. 2010;37(1):24-9. doi: 10.1159/000319051. Epub 2010 Jul 20. Pathophysiol Haemost Thromb. 2010. PMID: 20664190 Review.
-
[Vasculitis and vasculopathy].Acta Med Croatica. 2012 Oct;66 Suppl 1:19-24. Acta Med Croatica. 2012. PMID: 23193816 Review. Croatian.
Cited by
-
Plasminogen activator inhibitor-1: a potential etiological role in livedoid vasculopathy.Int Wound J. 2020 Dec;17(6):1902-1908. doi: 10.1111/iwj.13480. Epub 2020 Oct 11. Int Wound J. 2020. PMID: 33043622 Free PMC article. Review.
-
Livedoid vasculopathy and its association with genetic variants: A systematic review.Int Wound J. 2021 Oct;18(5):616-625. doi: 10.1111/iwj.13563. Epub 2021 Mar 8. Int Wound J. 2021. PMID: 33686673 Free PMC article.
-
Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management.Int J Womens Dermatol. 2021 Sep 2;7(5Part A):588-599. doi: 10.1016/j.ijwd.2021.08.013. eCollection 2021 Dec. Int J Womens Dermatol. 2021. PMID: 35024414 Free PMC article. Review.
-
Painless Livedoid Vasculopathy in a Patient with G20210A Prothrombin Gene Mutation.Case Rep Med. 2012;2012:910231. doi: 10.1155/2012/910231. Epub 2012 Sep 5. Case Rep Med. 2012. PMID: 22988463 Free PMC article.
-
Livedoid vasculopathy in a patient with lupus anticoagulant and MTHFR mutation: treatment with low-molecular-weight heparin.J Thromb Thrombolysis. 2012 Nov;34(4):541-4. doi: 10.1007/s11239-012-0743-5. J Thromb Thrombolysis. 2012. PMID: 22592843
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous